Quantcast

Latest heart diseases Stories

2014-09-18 16:27:32

ReportsnReports.com offers Acute Heart Failure - Pipeline Review, H1 2014 and Chronic Heart Failure Pipeline Review, H2 2014' research reports in its store. The reports provide an overview of the Acute Heart Failure's therapeutic pipeline and Chronic Heart Failure's therapeutic pipeline. DALLAS, Sept. 18, 2014 /PRNewswire-iReach/ -- These reports provide comprehensive information on the therapeutic development for Acute Heart Failure and Chronic Heart Failure, complete with comparative...

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-09-14 12:21:00

Dr. Gary Francis to receive 2014 Lifetime Achievement Award LAS VEGAS, Sept. 14, 2014 /PRNewswire/ -- The Heart Failure Society of America's (HFSA) 18(th) Annual Scientific Meeting convenes on Sunday, September 14(th), 2014 at the Caesars Palace Hotel in Las Vegas. This four-day meeting--a forum for heart failure specialists to present research findings and advances in treatment--will address emerging trends in research and new developments in the approach to treating patients with all stages...

2014-09-07 11:59:54

Heart disease is an umbrella term for a wide range of related conditions that affect the heart. Coronary heart disease is one example, resulting from plaque build-up on the inner walls of arteries – this reduces the blood flow to the heart and thereby increases the chances of experiencing a heart attack or other complication. Other common heart conditions include: Brugada Syndrome This is a condition that affects the heart rhythm by restricting the sodium ions in heart cells,...

One Hour Of Moderate Exercise A Day Could Decrease Risk Of Heart Failure
2014-09-03 03:21:10

American Heart Association In a new study reported in the American Heart Association journal Circulation: Heart Failure, researchers say more than an hour of moderate or half an hour of vigorous exercise per day may lower your risk of heart failure by 46 percent. Heart failure is a common, disabling disease that accounts for about 2 percent of total healthcare costs in industrialized countries. Risk of death within five years of diagnosis is 30 percent to 50 percent, researchers said....

2014-09-02 08:31:09

HOUSTON, Sept. 2, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), today announced results from the ANTHEM-HF clinical study. Results of the study presented by a prominent heart failure specialist during a major European cardiology congress and concurrently published by the Journal of Cardiac Failure show Autonomic Regulation Therapy (ART) in patients with moderate to severe chronic heart failure and impaired heart function is safe, improves the heart's ability to pump blood, and...

2014-08-30 12:21:03

Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug. 30, 2014 /PRNewswire/ -- Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation (VNS) for the treatment of heart failure patients. Faiez Zannad, M.D.,...

2014-08-13 08:26:49

SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is "highly warranted" to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional...

2014-08-12 08:31:39

CLEVELAND, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, Inc., a private clinical-stage company developing a drug-based approach to regenerative medicine today announced that it successfully completed the Phase I arm of the RETRO-HF clinical trial, and fully enrolled the Phase II arm that is evaluating the safety and preliminary clinical efficacy for retrograde infusion of JVS-100 in patients with heart failure....

2014-07-23 16:28:13

Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 /PRNewswire/ -- Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent(TM) Paclitaxel-Coated PTCA Balloon Catheter. The Agent Drug-Coated Balloon (DCB) provides physicians with an...


Latest heart diseases Reference Libraries

Cardiac Stress Test
2012-11-18 19:30:13

The cardiac stress test is a diagnostic test used in Cardiac pathology for the purpose of patient diagnosis. It measures the heart’s function while placing a heavier workload on the heart. The cardiologist cannot be at the patient’s side while at work, under stress, during a workout or pushed to the limit so this test mimics those activities in a controlled setting. How it is Performed The stress is created by increasing the workload on the cardiac system. This can be accomplished by...

More Articles (1 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.